Tilidine - Aoxing

Drug Profile

Tilidine - Aoxing

Alternative Names: Tilidate - Aoxing

Latest Information Update: 13 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aoxing Pharmaceutical Company
  • Class Cyclohexanecarboxylic acids; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cancer pain; Postoperative pain

Highest Development Phases

  • Registered Cancer pain; Postoperative pain

Most Recent Events

  • 07 May 2013 Preregistration for Cancer pain in China (PO)
  • 07 May 2013 Preregistration for Postoperative pain in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top